Oracle Investment Management as of March 31, 2016
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 20 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 18.8 | $72M | 5.0M | 14.37 | |
| Quidel Corporation | 11.6 | $44M | 2.6M | 17.26 | |
| Opko Health (OPK) | 10.6 | $41M | 3.9M | 10.39 | |
| NxStage Medical | 10.5 | $40M | 2.7M | 14.99 | |
| Mazor Robotics Ltd. equities | 9.4 | $36M | 2.9M | 12.44 | |
| Tesaro | 7.3 | $28M | 641k | 44.03 | |
| Pacific Biosciences of California (PACB) | 6.9 | $27M | 3.3M | 8.03 | |
| Accuray Incorporated (ARAY) | 3.8 | $15M | 2.6M | 5.78 | |
| Biolase Technology | 3.6 | $14M | 11M | 1.31 | |
| Intrexon | 3.6 | $14M | 404k | 33.89 | |
| Vermillion | 3.3 | $13M | 8.6M | 1.47 | |
| Hansen Medical | 3.0 | $12M | 4.5M | 2.61 | |
| Amarin Corporation (AMRN) | 2.3 | $8.9M | 5.8M | 1.53 | |
| shares Agenus | 2.0 | $7.8M | 1.9M | 4.16 | |
| Transition Therapeutics | 1.3 | $4.9M | 3.8M | 1.28 | |
| Contrafect | 1.1 | $4.0M | 1.2M | 3.40 | |
| Biogen Idec (BIIB) | 0.5 | $1.7M | 6.7k | 260.30 | |
| Metabolix | 0.4 | $1.4M | 727k | 1.90 | |
| Second Sight Med Prods | 0.1 | $245k | 51k | 4.82 | |
| ZIOPHARM Oncology | 0.0 | $49k | 6.7k | 7.36 |
